Literature DB >> 19756874

Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?

David Grande1.   

Abstract

Concerns over the influence of pharmaceutical gifts on physicians have surged in recent years. This has prompted wide ranging legislative proposals in numerous states and in the federal government as well as stepped up efforts at self-regulation by the pharmaceutical industry and the medical profession. Policymakers face the decision of whether to defer to self-regulation or support government intervention. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession. The author examines and critiques the wide ranging legislative strategies pursued to limit the influence of pharmaceutical gifts on physicians and concludes with suggestions for policymakers and the profession to limit influence and preserve public trust.

Mesh:

Year:  2009        PMID: 19756874      PMCID: PMC2811591          DOI: 10.1007/s11606-009-1016-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Industry-to-physician marketing and the cost of prescription drugs.

Authors:  Winston Chiong
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

3.  New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.

Authors:  Susan Chimonas; David J Rothman
Journal:  Health Aff (Millwood)       Date:  2005 Jul-Aug       Impact factor: 6.301

4.  Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.

Authors:  David M Studdert; Michelle M Mello; Troyen A Brennan
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

5.  The lessons of Vioxx--drug safety and sales.

Authors:  Henry A Waxman
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

6.  Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota.

Authors:  Joseph S Ross; Josh E Lackner; Peter Lurie; Cary P Gross; Sidney Wolfe; Harlan M Krumholz
Journal:  JAMA       Date:  2007-03-21       Impact factor: 56.272

7.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Authors:  Troyen A Brennan; David J Rothman; Linda Blank; David Blumenthal; Susan C Chimonas; Jordan J Cohen; Janlori Goldman; Jerome P Kassirer; Harry Kimball; James Naughton; Neil Smelser
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

8.  Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.

Authors:  David J Rothman; Walter J McDonald; Carol D Berkowitz; Susan C Chimonas; Catherine D DeAngelis; Ralph W Hale; Steven E Nissen; June E Osborn; James H Scully; Gerald E Thomson; David Wofsy
Journal:  JAMA       Date:  2009-04-01       Impact factor: 56.272

9.  A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.

Authors:  R V Gibbons; F J Landry; D L Blouch; D L Jones; F K Williams; C R Lucey; K Kroenke
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

10.  A national survey of physician-industry relationships.

Authors:  Eric G Campbell; Russell L Gruen; James Mountford; Lawrence G Miller; Paul D Cleary; David Blumenthal
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

View more
  20 in total

Review 1.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

2.  The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.

Authors:  Alison R Hwong; Sunita Sah; Lisa Soleymani Lehmann
Journal:  J Gen Intern Med       Date:  2017-07-17       Impact factor: 5.128

3.  On the psychology of pharmaceutical industry gifts to physicians.

Authors:  Donald A Redelmeier
Journal:  J Gen Intern Med       Date:  2010-01       Impact factor: 5.128

4.  Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.

Authors:  Christopher Scott Brunt
Journal:  Health Serv Res       Date:  2018-10-01       Impact factor: 3.402

5.  Prescription Opioid Misuse and Overuse in the U.S.

Authors:  David A Fleming
Journal:  Mo Med       Date:  2018 May-Jun

6.  Unhealthy marketing of pharmaceutical products: An international public health concern.

Authors:  Shai Mulinari
Journal:  J Public Health Policy       Date:  2016-02-25       Impact factor: 2.222

7.  The Invisible Hand of Industry.

Authors:  X Mona Guo; Emma L Barber
Journal:  Clin Obstet Gynecol       Date:  2022-02-28       Impact factor: 1.966

8.  Should physicians rely on pharmaceutical detailing for their education?

Authors:  Johan M van Schalkwyk; Martin J Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-14       Impact factor: 3.738

9.  Disparities in industry funding among Colorectal Surgeons: a cross-sectional study.

Authors:  Alessandra Storino; Carolina Vigna; John C Polanco-Santana; Ernest Park; Kristen Crowell; Anne Fabrizio; Thomas E Cataldo; Evangelos Messaris
Journal:  Surg Endosc       Date:  2022-02-01       Impact factor: 3.453

10.  Attitude and practice of dental surgeons towards pharmaceutical companies' marketing gifts.

Authors:  Shaila Tahir; Adeela Rafique; Farkhanda Ghafoor; Akif Saleem; Amanullah Khan
Journal:  J Med Ethics Hist Med       Date:  2013-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.